Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.
about
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Clinicopathological characteri ...... on tyrosine kinase inhibitors.
@en
Clinicopathological characteri ...... on tyrosine kinase inhibitors.
@nl
type
label
Clinicopathological characteri ...... on tyrosine kinase inhibitors.
@en
Clinicopathological characteri ...... on tyrosine kinase inhibitors.
@nl
prefLabel
Clinicopathological characteri ...... on tyrosine kinase inhibitors.
@en
Clinicopathological characteri ...... on tyrosine kinase inhibitors.
@nl
P2093
P2860
P356
P1476
Clinicopathological characteri ...... ton tyrosine kinase inhibitors
@en
P2093
F Anthony San Lucas
Jorge Romaguera
Leonard Jeffrey Medeiros
Loretta Nastoupil
Luis Fayad
Michael Wang
Nathan Fowler
Rashmi Kanagal-Shamanna
Yasuhiro Oki
P2860
P304
P356
10.1111/BJH.14857
P407
P577
2017-08-02T00:00:00Z